Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page has updated its schedule with new dates for 2025 and removed previous dates, along with a change in the name of a facility from a radiological institute to a pharmacy.SummaryDifference0.5%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check27 days agoChange DetectedThe page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
- Check34 days agoChange DetectedThe page has been updated to include the HHS Vulnerability Disclosure and has revised its version number to v2.16.8, while removing older dates and the previous version v2.16.6.SummaryDifference0.2%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.0%
- Check49 days agoChange DetectedThe page has been updated to reflect a planned maintenance alert starting July 25th, during which most services will be unavailable for over 24 hours. Additionally, the name of the hospital has been corrected to 'Hopital prive du Confluent S.A.S.' and the location details have been refined.SummaryDifference3%
Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.